Volume 69 Received 24 November 2012 | |||||||||||
| |||||||||||
P}gold(I) chloroform 0.25-solvateaDepartment of Chemistry, University of Cape Town, Private Bag, Rondebosch, 7707, South Africa, and bResearch Centre for Synthesis and Catalysis, Department of Chemistry, University of Johannesburg (APK Campus), PO Box 524, Auckland Park, Johannesburg, 2006, South Africa
Correspondence e-mail: harrychiririwa@yahoo.com
The asymmetric unit of the title compound, [AuCl(C31H32NP)]·0.25CHCl3, contains two independent complex molecules and half a chloroform solvent molecule, which is disordered across an inversion center. The AuI ions are each coordinated in a slightly distorted linear environment, with P-Au-Cl angles of 177.20 (4) and 178.54 (4)°.
For general background to gold complexes, see: Shaw (1999
); Barnard et al. (2004
); Nomiya et al. (2003
). For applications of gold-containing drugs, see: Chiririwa et al. (2013
); Fricker (1996
); Cowan (1993
); Parish (1992
); Finkelstein et al. (1976
). For the synthesis of the starting materials, see: Mogorosi et al. (2011
); Uson & Laguna (1986
); Reddy et al. (2002
). For similar compounds, see: Chiririwa & Muller (2012
); Williams et al. (2007
).
|
Data collection: APEX2 (Bruker, 2007
); cell refinement: SAINT (Bruker, 2007
); data reduction: SAINT and XPREP (Bruker, 2007
); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: DIAMOND (Brandenburg & Putz, 2005
); software used to prepare material for publication: WinGX (Farrugia, 2012)
.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: LH5564 ).
Mintek and Project AuTEK are acknowledged for funding this project. HC also thanks the late Professor J. R. Moss for fruitful discussions.
Barnard, P. J., Baker, M. V., Berners-Price, S. J. & Day, D. A. (2004). J. Inorg. Biochem. 98, 115-119.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Brandenburg, K. & Putz, H. (2005). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Bruker (2007). APEX2, SAINT, SADABS, and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.
Chiririwa, H., Moss, J. R., Hendricks, D., Smith, G. S. & Meijboom, R. (2013). Polyhedron, 49, 29-35.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Chiririwa, H. & Muller, A. (2012). Acta Cryst. E68, m49.
![[details]](../../../../../../e/graphics/details.gif)
Cowan, J. A. (1993). Inorganic Biochemistry: An Introduction, pp. 277-280. Weinheim: VCH.
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Finkelstein, A. E., Walz, D. T., Batista, U. M., Mixraji, M., Roisman, F. & Misher, A. (1976). Ann. Rheum. Dis. 35, 251-257.
![[ISI]](../../../../../../logos/isiborder.gif)
Fricker, S. R. (1996). Gold Bull. 29, 53-60. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Mogorosi, M. M., Mahamo, T., Moss, J. R., Mapolie, S. F., Slootweg, J. C., Lammertsma, K. & Smith, G. S. (2011). J. Organomet. Chem. 696, 3585-3592.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Nomiya, K., Yamamoto, S., Noguchi, R., Yokoyama, H., Kasuga, N. C., Ohyama, K. & Kato, C. (2003). J. Inorg. Biochem. 95, 2208-2220.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Parish, R. V. (1992). Interdisc. Sci. Rev. 17, 221-228.
Reddy, K. R., Tsai, W.-W., Lee, S. G.-H., Peng, S. M., Chen, J.-T. & Liu, S. T. (2002). J. Chem. Soc. Dalton Trans. pp. 1776-1782.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Shaw, C. F. III (1999). Chem. Rev. 99, 2589-2600.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Uson, R. & Laguna, A. (1986). Organometallic Synthesis, edited by R. B. Lang & J. J. Eish, Vol. 3, pp. 324-327. Amsterdam: Elsevier.
Williams, D. B. G., Traut, T., Kriel, F. H. & van Zyl, W. E. (2007). Inorg. Chem. Commun. 10, 538-542.
![[ChemPort]](../../../../../../logos/chemportborder.gif)